TES of Artemether-lumefantrine for Pf and Chloroquine for Pv in the Philippines From 2013-2014

CompletedOBSERVATIONAL
Enrollment

159

Participants

Timeline

Start Date

May 1, 2013

Primary Completion Date

December 30, 2014

Study Completion Date

December 30, 2014

Conditions
MalariaFalciparum MalariaVivax MalariaMalaria Recrudescence
Interventions
DRUG

Arthemeter-lumefantrine

"Artemether-lumefantrine will be administered for 3 days according to body weight (Days 0 and 8 hours after, 1 and 2). Dosage depending on body weight or age if weight cannot be determined.~Dosage: 1 tablet contains 20 mg artemether and 120 mg lumefantrine Dosage per weight: 1 tablet (5 to \<16kg); 2 tablets (15 to \<25kg); 3 tablets (25 to \<35kg), 4 tablets for \>35 kg) Dosage per age, if weight cannot be determined: 1 tablet (6 months old to 3 years old); 2 tablets (4 to 8 years old); 3 tablets (9-13 years old), 4 tablets (\>13 years old)"

DRUG

Chloroquine

Chloroquine will be administered according to body weight at a total dose of 25 mg base/kg over 3 days (10 mg base/kg on Day 0; 10 mg base/kg on Day 1 and 5 mg base/kg on Day 2). Correct drug dosage will be determined using the dosing chart (in accordance with national treatment guidelines)

DRUG

Primaquine

For Pf patients, primaquine at 0.75 mg base/kg body weight single dose will be given on Day 3 for Pf patients; For Pv patients primaquine will be withheld for 28 days and will be given after Day 28 follow-up, at 0.25 mg base/kg per day for 14 days.

All Listed Sponsors
collaborator

World Health Organization

OTHER

lead

Research Institute for Tropical Medicine, Philippines

OTHER_GOV

NCT04222088 - TES of Artemether-lumefantrine for Pf and Chloroquine for Pv in the Philippines From 2013-2014 | Biotech Hunter | Biotech Hunter